ANRIL is a well-known functional lncRNAassociated with multiple human diseases, particularlyinflammatory diseases such as atherosclerosis (11).Given that dysregulation of ANRIL is associated withmany diseases, ANRIL can be considered as a potentialbiomarker and therapeutic target (22). This evidence concerns the gene CDKN2B-AS1 and atherosclerosis.